CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ADAPTOGENS MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Ashwagandha
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Ginseng
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Astragalus
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Holy Basils
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Rhodiola Roseas
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Schisandra
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Adaptogenic mushrooms
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Others
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
CHAPTER 5: ADAPTOGENS MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 Powder
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Capsules
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Teas and Beverages
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: ADAPTOGENS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Food and Beverages
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Dietary and sports supplements
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Cosmetics
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Animal Feed
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Pharmaceutical
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL
7.1 Overview
7.1.1 Market size and forecast
7.2 Business to Business
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Business to Consumer
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.3.4 Business to Consumer Adaptogens Market by Sales channel
7.3.4.1 Supermarket and hypermarket Market size and forecast, by region
7.3.4.2 Specialty store Market size and forecast, by region
7.3.4.3 Pharmacies and drug stores Market size and forecast, by region
7.3.4.4 Others Market size and forecast, by region
CHAPTER 8: ADAPTOGENS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Source
8.2.3 North America Market size and forecast, by End Use
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by Distribution Channel
8.2.5.1 North America Business to Consumer Adaptogens Market by Sales channel
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Source
8.2.6.1.2 Market size and forecast, by End Use
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by Distribution Channel
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Source
8.2.6.2.2 Market size and forecast, by End Use
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by Distribution Channel
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Source
8.2.6.3.2 Market size and forecast, by End Use
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by Distribution Channel
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Source
8.3.3 Europe Market size and forecast, by End Use
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by Distribution Channel
8.3.5.1 Europe Business to Consumer Adaptogens Market by Sales channel
8.3.6 Europe Market size and forecast, by country
8.3.6.1 UK
8.3.6.1.1 Market size and forecast, by Source
8.3.6.1.2 Market size and forecast, by End Use
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by Distribution Channel
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Source
8.3.6.2.2 Market size and forecast, by End Use
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by Distribution Channel
8.3.6.3 Germany
8.3.6.3.1 Market size and forecast, by Source
8.3.6.3.2 Market size and forecast, by End Use
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by Distribution Channel
8.3.6.4 France
8.3.6.4.1 Market size and forecast, by Source
8.3.6.4.2 Market size and forecast, by End Use
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by Distribution Channel
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Source
8.3.6.5.2 Market size and forecast, by End Use
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by Distribution Channel
8.3.6.6 The Netherlands
8.3.6.6.1 Market size and forecast, by Source
8.3.6.6.2 Market size and forecast, by End Use
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by Distribution Channel
8.3.6.7 Switzerland
8.3.6.7.1 Market size and forecast, by Source
8.3.6.7.2 Market size and forecast, by End Use
8.3.6.7.3 Market size and forecast, by Application
8.3.6.7.4 Market size and forecast, by Distribution Channel
8.3.6.8 Rest of Europe
8.3.6.8.1 Market size and forecast, by Source
8.3.6.8.2 Market size and forecast, by End Use
8.3.6.8.3 Market size and forecast, by Application
8.3.6.8.4 Market size and forecast, by Distribution Channel
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Source
8.4.3 Asia-Pacific Market size and forecast, by End Use
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by Distribution Channel
8.4.5.1 Asia-Pacific Business to Consumer Adaptogens Market by Sales channel
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Source
8.4.6.1.2 Market size and forecast, by End Use
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by Distribution Channel
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Source
8.4.6.2.2 Market size and forecast, by End Use
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by Distribution Channel
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Source
8.4.6.3.2 Market size and forecast, by End Use
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by Distribution Channel
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Source
8.4.6.4.2 Market size and forecast, by End Use
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by Distribution Channel
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Source
8.4.6.5.2 Market size and forecast, by End Use
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by Distribution Channel
8.4.6.6 Indonesia
8.4.6.6.1 Market size and forecast, by Source
8.4.6.6.2 Market size and forecast, by End Use
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by Distribution Channel
8.4.6.7 Thailand
8.4.6.7.1 Market size and forecast, by Source
8.4.6.7.2 Market size and forecast, by End Use
8.4.6.7.3 Market size and forecast, by Application
8.4.6.7.4 Market size and forecast, by Distribution Channel
8.4.6.8 Rest of Asia-Pacific
8.4.6.8.1 Market size and forecast, by Source
8.4.6.8.2 Market size and forecast, by End Use
8.4.6.8.3 Market size and forecast, by Application
8.4.6.8.4 Market size and forecast, by Distribution Channel
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Source
8.5.3 LAMEA Market size and forecast, by End Use
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by Distribution Channel
8.5.5.1 LAMEA Business to Consumer Adaptogens Market by Sales channel
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Source
8.5.6.1.2 Market size and forecast, by End Use
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by Distribution Channel
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Source
8.5.6.2.2 Market size and forecast, by End Use
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by Distribution Channel
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Source
8.5.6.3.2 Market size and forecast, by End Use
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by Distribution Channel
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Dabur India Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Emami Limited
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 kairali ayurvedic group
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Himalaya Wellness
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Colgate-Palmolive Company
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Procter & Gamble
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Patanjali Ayurved Limited
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Shahnaz Ayurveda Pvt. Ltd.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Unilever
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 ENOMARK BIOTECH (ENOMARK HEALTHCARE)
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Riaan Wellness Pvt. Ltd.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 .Givaudan International SA (NATUREX S.A.)
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 PLT Health Solutions
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 INDENA S.P.A
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
